| Date Filed | Type | Description |
| 07/03/2023 |
4
| KINGSLEY ALFRED D (Chairman) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.41, valued at
$70.5k
|
|
| 06/15/2023 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on Oncocyte Corp|
Txns:
| Bought 30,000 shares
@ $0.2149, valued at
$6.4k
|
|
| 12/27/2022 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on Oncocyte Corp|
Txns:
| Bought 25,000 shares
@ $0.285, valued at
$7.1k
|
|
| 08/17/2022 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on Oncocyte Corp|
Txns:
| Granted 10,000 shares
@ $0
Bought 5,000 shares
@ $0.97, valued at
$4.9k
Granted 45,000 options to buy
@ $0.97, valued at
$43.7k
|
|
| 07/19/2022 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on Oncocyte Corp|
Txns:
| Exercised 10,000 restricted stock units
@ $0 |
|
| 07/06/2022 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.57, valued at
$78.5k
|
|
| 02/11/2022 |
5
| KINGSLEY ALFRED D (Director) has filed a Form 5 on Lineage Cell Therapeutics, Inc. |
| 07/01/2021 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $2.86, valued at
$228.8k
|
|
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Exercised 61,800 options to buy
@ $2.2, valued at
$136k
|
|
| 02/12/2021 |
5
| KINGSLEY ALFRED D (Director) has filed a Form 5 on Lineage Cell Therapeutics, Inc. |
| 12/28/2020 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on OncoCyte Corp|
Txns:
| Sold 900 shares
@ $2.55, valued at
$2.3k
Exercised 1,237 options to buy
@ $1.34, valued at
$1.7k
Exercised 65,271 options to buy
@ $1.34, valued at
$87.5k
|
|
| 12/23/2020 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on OncoCyte Corp|
Txns:
| Sold 30,000 shares
@ $0
Sold 5,148 shares
@ $2.54, valued at
$13.1k
Sold 7,652 shares
@ $0
Exercised 47,976 options to buy
@ $1.34, valued at
$64.3k
Exercised 10,516 options to buy
@ $1.34, valued at
$14.1k
|
|
| 12/15/2020 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 5,909 shares
@ $0 |
|
| 12/15/2020 |
4/A
| KINGSLEY ALFRED D (Director) has filed a Form 4 on OncoCyte Corp |
| 07/02/2020 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 70,000 options to buy
@ $0.8263, valued at
$57.8k
|
|
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
5
| KINGSLEY ALFRED D (Director) has filed a Form 5 on Lineage Cell Therapeutics, Inc. |
| 07/19/2019 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 45,000 options to buy
@ $2.12, valued at
$95.4k
|
|
| 07/03/2019 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Granted 70,000 options to buy
@ $1.03, valued at
$72.1k
|
|
| 04/05/2019 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Granted 6,390 shares
@ $0 |
|
| 02/14/2019 |
5
| KINGSLEY ALFRED D (Director) has filed a Form 5 on BIOTIME INC |
| 09/04/2018 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 45,000 options to buy
@ $2.4, valued at
$108k
|
|
| 07/03/2018 |
4
| KINGSLEY ALFRED D (See Remarks) has filed a Form 4 on BIOTIME INC|
Txns:
| Granted 70,000 options to buy
@ $2.06, valued at
$144.2k
|
|
| 02/14/2018 |
5
| KINGSLEY ALFRED D (See Remarks) has filed a Form 5 on BIOTIME INC |
| 08/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2017 |
4
| KINGSLEY ALFRED D (See Remarks) has filed a Form 4 on BIOTIME INC|
Txns:
| Sold 150,000 shares
@ $2.8, valued at
$420k
|
|
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/19/2017 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 16,300 options to buy
@ $5.1, valued at
$83.1k
Granted 50,000 options to buy
@ $5.1, valued at
$255k
|
|
| 01/10/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2017 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 07/05/2016 |
4
| KINGSLEY ALFRED D (See Remarks) has filed a Form 4 on BIOTIME INC |
| 03/01/2016 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.64, valued at
$72.8k
|
|
|